We are pleased to present the scope of the journal...
With a 2011 impact factor of 7.99 Neuropsychopharmacology ranks 6th of 129 Psychiatry journals, 9th of 261 Pharmacology and Pharmacy journals, and 17th of 243 Neuroscience journals. 97% of accepted articles are published online in less than 25 business days and in print in less than 71 business days. In 2011, all issues of Neuropsychopharmacology were published on or ahead of schedule.
Online readership spiked in 2011 with almost 1.8 million page views, almost 850,000 site visits, and over 1 million article views. The site averaged 2,500 visits per day and 56% of the page views were from outside the US. More than 100,000 individuals registered for NPP's electronic table of contents alerts, making it more subscribed to than Nature Neuroscience.
Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behaviour, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office.
In view of the interdisciplinary nature of the field, particular emphasis is placed on:
studies that advance the biological bases of normal and pathological behavior
the nature, etiology and pathophysiology of neuropsychiatric disorders
biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders
the basic mechanisms by which psychopharmacological agents exert their effect
Dr William A Carlezon Jr, PhD
Editor-in-Chief
Editors
Instructions for Authors:
- Submission (includes registering for an account, formatting, and process)
- Editorial Policy (includes Disclosure Policy and Conflict of Interest forms)
Instructions for Reviewers: